2m 2m 2m 2m 2m 2m 2m
NEUROGENE (NGNE)
NASDAQ
$33.29+$0.40 (+1.22%)
Price as of Aug 03, 2026 11:34 AM EDT- $656.2MMarket Cap
- 51.01%1-Year Change
- BiotechnologyIndustry
NEUROGENE (NGNE)
$33.29+$0.40 (+1.22%)
Earnings Score
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 0 |
Momentum Score
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 23.42% | ||
12-Month Momentum | 55.63% | ||
3-Month Risk Adjusted Momentum | 90.92% | ||
12-Month Risk Adjusted Momentum | 70.28% |
True Yield
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | NGNE | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | -1 |